These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17134027)
1. A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptors. Ishiwata K; Oda K; Sakata M; Kimura Y; Kawamura K; Oda K; Sasaki T; Naganawa M; Chihara K; Okubo Y; Ishii K Ann Nucl Med; 2006 Oct; 20(8):569-73. PubMed ID: 17134027 [TBL] [Abstract][Full Text] [Related]
2. Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands. Ishiwata K; Kawamura K; Kobayashi T; Matsuno K Nucl Med Biol; 2003 May; 30(4):429-34. PubMed ID: 12767400 [TBL] [Abstract][Full Text] [Related]
3. Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503. Sakata M; Kimura Y; Naganawa M; Oda K; Ishii K; Chihara K; Ishiwata K Neuroimage; 2007 Mar; 35(1):1-8. PubMed ID: 17240168 [TBL] [Abstract][Full Text] [Related]
4. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Farde L; Suhara T; Nyberg S; Karlsson P; Nakashima Y; Hietala J; Halldin C Psychopharmacology (Berl); 1997 Oct; 133(4):396-404. PubMed ID: 9372541 [TBL] [Abstract][Full Text] [Related]
5. [11C]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [11C]SA4503 binding was not by raclopride. Ishiwata K; Kobayashi T; Kawamura K; Matsuno K; Senda M Nucl Med Biol; 2001 Oct; 28(7):787-92. PubMed ID: 11578899 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor. Elsinga PH; Kawamura K; Kobayashi T; Tsukada H; Senda M; Vaalburg W; Ishiwata K Synapse; 2002 Mar; 43(4):259-67. PubMed ID: 11835521 [TBL] [Abstract][Full Text] [Related]
7. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [ Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210 [TBL] [Abstract][Full Text] [Related]
9. Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients. Nyberg S; Farde L; Halldin C Psychiatry Res; 1996 Oct; 67(3):163-71. PubMed ID: 8912956 [TBL] [Abstract][Full Text] [Related]
10. Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study. Suzuki T; Graff-Guerrero A; Uchida H; Remington G; Caravaggio F; Borlido C; Pollock B; Mulsant B; Deluca V; Ismail Z; Mamo D Psychopharmacology (Berl); 2013 Jul; 228(1):43-51. PubMed ID: 23417515 [TBL] [Abstract][Full Text] [Related]
11. Imaging of sigma1 receptors in the human brain using PET and [11C]SA4503. Toyohara J; Sakata M; Ishiwata K Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):190-6. PubMed ID: 20021353 [TBL] [Abstract][Full Text] [Related]
12. High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503. Ishikawa M; Sakata M; Ishii K; Kimura Y; Oda K; Toyohara J; Wu J; Ishiwata K; Iyo M; Hashimoto K Int J Neuropsychopharmacol; 2009 Sep; 12(8):1127-31. PubMed ID: 19573265 [TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of [11C]SA4503: radiation dosimetry, in vivo selectivity and PET imaging of sigma1 receptors in the cat brain. Kawamura K; Ishiwata K; Shimada Y; Kimura Y; Kobayashi T; Matsuno K; Homma Y; Senda M Ann Nucl Med; 2000 Aug; 14(4):285-92. PubMed ID: 11023029 [TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598 [TBL] [Abstract][Full Text] [Related]
15. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine. Kodaka F; Ito H; Takano H; Takahashi H; Arakawa R; Miyoshi M; Okumura M; Otsuka T; Nakayama K; Halldin C; Farde L; Suhara T Int J Neuropsychopharmacol; 2011 Feb; 14(1):83-9. PubMed ID: 20860881 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of (+)-p-[11C]methylvesamicol for mapping sigma1 receptors: a comparison with [11C]SA4503. Ishiwata K; Kawamura K; Yajima K; QingGeLeTu ; Mori H; Shiba K Nucl Med Biol; 2006 May; 33(4):543-8. PubMed ID: 16720247 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial σ1-receptor stimulation with SA4503 rescues aortic relaxation via Akt/eNOS signaling in ovariectomized rats with aortic banding. Tagashira H; Matsumoto T; Taguchi K; Zhang C; Han F; Ishida K; Nemoto S; Kobayashi T; Fukunaga K Circ J; 2013; 77(11):2831-40. PubMed ID: 23965801 [TBL] [Abstract][Full Text] [Related]
18. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol. Kessler RM; Ansari MS; Riccardi P; Li R; Jayathilake K; Dawant B; Meltzer HY Neuropsychopharmacology; 2005 Dec; 30(12):2283-9. PubMed ID: 16123775 [TBL] [Abstract][Full Text] [Related]
19. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia. Tateno A; Arakawa R; Okumura M; Fukuta H; Honjo K; Ishihara K; Nakamura H; Kumita S; Okubo Y J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of [11C]SA5845 and [11C]SA4503 for imaging of sigma receptors in tumors by animal PET. Kawamura K; Kubota K; Kobayashi T; Elsinga PH; Ono M; Maeda M; Ishiwata K Ann Nucl Med; 2005 Dec; 19(8):701-9. PubMed ID: 16444997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]